Cargando…

Liver Abnormalities after Elimination of HCV Infection: Persistent Epigenetic and Immunological Perturbations Post-Cure

Chronic hepatitis C (CHC) is a major cause of hepatocellular carcinoma (HCC) worldwide. While directly acting antiviral (DAA) drugs are now able to cure virtually all hepatitis C virus (HCV) infections, even in subjects with advanced liver disease, what happens to the liver and progression of the di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polyak, Stephen J., Crispe, I. Nicholas, Baumert, Thomas F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825776/ https://www.ncbi.nlm.nih.gov/pubmed/33430338 http://dx.doi.org/10.3390/pathogens10010044

Ejemplares similares

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
por: Brochado-Kith, Óscar, et al.
Publicado: (2021)

Memories of Stress: The Imprinted Cancer Risk After HCV Cure
por: Lupberger, Joachim, et al.
Publicado: (2023)

HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response
por: Hamdane, Nourdine, et al.
Publicado: (2019)

Persistence of Cryoglobulinemic Vasculitis after DAA Induced HCV Cure
por: Danishwar, Mahmood, et al.
Publicado: (2022)

Epidemiology and Elimination of HCV-Related Liver Disease
por: Pradat, Pierre, et al.
Publicado: (2018)

Addressing the Challenges of Hepatitis C Cure and Persistent Risk of Hepatocellular Carcinoma
por: Baumert, Thomas F., et al.
Publicado: (2019)

Need to Face Liver Cirrhosis after HCV Cure with Antivirals
por: Soriano, Vicente, et al.
Publicado: (2017)

Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells
por: Plumlee, Courtney R, et al.
Publicado: (2005)

HCV cure without interferon
por: Bourlière, Marc
Publicado: (2014)

Is HCV elimination possible in prison?
por: Crespo, J., et al.
Publicado: (2017)

Remaining challenges in HCV elimination
por: Capraru, Camelia, et al.
Publicado: (2021)

HCV elimination among people who inject drugs. Modelling pre- and post–WHO elimination era
por: Gountas, Ilias, et al.
Publicado: (2018)

Elimination of HCV in Russia: Barriers and Perspective
por: Isakov, Vasily, et al.
Publicado: (2022)

Long-Term Persistence of Mitochondrial DNA Instability among HCV-Cured People Who Inject Drugs
por: Durand, Mélusine, et al.
Publicado: (2022)

Priming persistence of HCV
por: Schuch, Anita, et al.
Publicado: (2015)

Glances in Immunology of HIV and HCV Infection
por: Quaranta, Maria Giovanna, et al.
Publicado: (2012)

Immunologic Predictors of Liver Transplantation Outcomes in HIV-HCV Co-Infected Persons
por: Balagopal, Ashwin, et al.
Publicado: (2015)

HCV cure for everyone or which challenges remain?
por: Rockstroh, Jürgen Kurt
Publicado: (2015)

Eliminating HCV: a marathon, not a sprint
por: The Lancet Gastroenterology & Hepatology
Publicado: (2020)

P Selectins and immunological profiles in HCV and Schistosoma mansoni induced chronic liver disease
por: Kamel, Mahmoud M, et al.
Publicado: (2014)

Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape
por: Colpitts, Che C, et al.
Publicado: (2018)

Immunological HCV-Associated Thrombocytopenia: Short Review
por: Dimitroulis, Dimitrios, et al.
Publicado: (2012)

Editorial: Recent Advances in HBV and HCV Immunology
por: Dustin, Lynn B., et al.
Publicado: (2015)

Atropine: A Cure for Persistent Post Laparoscopic Pyloromyotomy Emesis?
por: Cubas, Robert Frank, et al.
Publicado: (2017)

Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection
por: Boriskin, Yury S, et al.
Publicado: (2006)

Modeling HCV disease in animals: virology, immunology and pathogenesis of HCV and GBV-B infections
por: Manickam, Cordelia, et al.
Publicado: (2014)

Impact of COVID-19 on global HCV elimination efforts
por: Blach, Sarah, et al.
Publicado: (2021)

Perspectives of hepatitis C virus (HCV) elimination in Poland
por: Flisiak, Robert, et al.
Publicado: (2019)

Impact of the COVID-19 pandemic on HCV elimination in Spain
por: Buti, Maria, et al.
Publicado: (2021)

Editorial: Legacies of epigenetic perturbations
por: da Rocha, Simão Teixeira, et al.
Publicado: (2023)

Complete differentiation of CD8(+) T cells activated locally within the transplanted liver
por: Klein, Ingo, et al.
Publicado: (2006)

Hepatic irradiation persistently eliminates liver resident NK cells
por: Nakano, Ryosuke, et al.
Publicado: (2018)

Targeted Immunology for Prevention and Cure of VL
por: Ali, Nahid, et al.
Publicado: (2014)

Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors
por: Carrieri, Patrizia, et al.
Publicado: (2022)

High sustained viral response among HCV genotype 3 patients with advanced liver fibrosis: real-world data of HCV elimination program in Georgia
por: Butsashvili, Maia, et al.
Publicado: (2020)

Signatures of immune dysfunction in HIV and HCV infection share features with chronic inflammation in aging and persist after viral reduction or elimination
por: Lopez Angel, Cesar J., et al.
Publicado: (2021)

A new paradigm evaluating cost per cure of HCV infection in the UK
por: Barclay, Stephen T., et al.
Publicado: (2016)

Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways
por: Mangia, Alessandra, et al.
Publicado: (2021)

Histological changes in HCV antibody–positive, HCV RNA–negative subjects suggest persistent virus infection
por: Hoare, Matthew, et al.
Publicado: (2008)

149 HCV AND lymphoma: Genetic and epigenetic factors
por: Zignego, AL, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e4qe6fuv380j9vg2ghmhpcb2ob